Private equity firm Carlyle Group is preparing to offload up to a 10% stake in India’s Piramal Pharma, online news portal Moneycontrol reported on Thursday, citing sources. The U.S.-based firm could earn in the range of 26 billion rupees ($304.8 million) to 27 billion rupees from the sale via block trades, the report added. Carlyle Group, through its affiliate Ca Alchemy Investments, had a 18% stake in Piramal Pharma as of March-end this year, exchange data showed.
Read the full article: Carlyle to Sell up to 10% Stake in Piramal Pharma, Moneycontrol Reports //
Source: https://finance.yahoo.com/news/carlyle-sell-10-stake-piramal-112917440.html